Venous malformation (VM) is a low-flow vascular malformation composed of dysplastic venous channels. It is congenital — present at birth and grows proportionally with the child, showing no spontaneous involution. It is the most common type of vascular malformation. Superficially located VMs typically present as blue-purple, soft, compressible masses. Ultrasonography is the primary diagnostic modality; compressibility and Valsalva filling are pathognomonic findings. The presence of phleboliths strongly supports the diagnosis. May be associated with TEK (TIE2/PIK3CA) mutations.
Age Range
0-80
Peak Age
20
Gender
Equal
Prevalence
Uncommon
Venous malformation results from somatic mutations in vascular endothelial cells (TIE2/TEK or PIK3CA). These mutations disrupt signaling pathways regulating endothelial cell proliferation and venous channel formation, leading to the development of dysplastic, dilated, thin-walled venous channels. These channels lack normal smooth muscle layer — smooth muscle cells present in the tunica media of normal vein walls are markedly decreased or absent in dysplastic vessels. The ultrasonographic manifestation of this smooth muscle deficiency is compressibility: when external pressure is applied (with the probe), the structure easily collapses because there is no wall resistance. Valsalva maneuver increases intrathoracic pressure, impedes venous return, and dysplastic channels passively fill — this is seen on US as increased lesion size and has pathognomonic diagnostic value. Phlebolith formation results from thrombus formation within stagnant venous channels and subsequent calcification — the lamellar structure of phleboliths reflects concentric organization of the thrombus. On US, phleboliths appear as echogenic foci with posterior acoustic shadowing. On MRI, T2 hyperintense appearance results from the long T2 relaxation time of slowly flowing blood within venous channels.
A soft tissue mass that completely collapses with probe compression and shows significant size increase with Valsalva maneuver is the pathognomonic finding pair of venous malformation. These two dynamic tests together distinguish venous malformation from all other soft tissue masses and vascular lesions.
On B-mode US, venous malformation appears as a heterogeneous echogenicity, irregularly marginated, compressible mass. Dilated venous channels (anechoic tubular structures) and solid areas in the stroma (hypoechoic-isoechoic) are seen within. When compression is applied with the probe, the lesion completely or substantially collapses — this compressibility is the pathognomonic diagnostic finding of venous malformation and reflects the thin-walled, smooth muscle-deficient dysplastic vessel structure.
Report Sentence
A mass with heterogeneous echogenicity containing dilated venous channels in the subcutaneous tissue, completely collapsing with probe compression, is seen, consistent with venous malformation.
During Valsalva maneuver, venous malformation shows significant size increase — the lesion swells and dilated venous channels become more prominent. This real-time dynamic finding has pathognomonic diagnostic value and distinguishes venous malformation from all other soft tissue masses. Lesions that are small or barely visible at rest may enlarge dramatically with Valsalva.
Report Sentence
Significant lesion size increase and venous channel distension with Valsalva maneuver is noted, a pathognomonic finding consistent with venous malformation.
The presence of phleboliths within venous malformation strongly supports the diagnosis. On US, they appear as echogenic foci with posterior acoustic shadowing. The lamellar structure of phleboliths reflects calcification of organized thrombus. Phlebolith size may vary from several mm to cm. Phlebolith presence is nearly specific to VM among vascular malformations — not typically seen in lymphatic malformation or hemangioma.
Report Sentence
Echogenic foci with posterior acoustic shadowing (phleboliths) are identified within the lesion, supporting the diagnosis of venous malformation.
On color and power Doppler, venous malformation shows no flow or very minimal, low-velocity monophasic venous flow. This low-flow pattern provides definitive differentiation from high-flow vascular lesions (infantile hemangioma, AVM). On spectral Doppler, detected flow shows low-velocity (<3 cm/s), continuous venous waveform. No arterial flow is present — arterial signal presence should favor AVM or hemangioma.
Report Sentence
On color and power Doppler examination, no flow is identified within the lesion, consistent with low-flow vascular malformation (venous malformation).
On MRI T2-weighted sequences, venous malformation appears as a markedly hyperintense, lobulated mass. Dilated venous channels show fluid-bright signal. Septae and stroma show low signal. Flow voids are absent — this is an important negative finding for differentiating from infantile hemangioma and AVM. T2 hyperintensity reflects the water-like signal characteristics of slowly flowing blood and stagnant venous pools.
Report Sentence
A markedly hyperintense lobulated mass is seen on T2-weighted sequences without flow voids — consistent with low-flow venous malformation.
On contrast-enhanced MRI, venous malformation shows progressive delayed enhancement. Minimal or no enhancement is seen in early phase, with progressive filling and enhancement in delayed phase. This pattern reflects slow flow within venous channels — contrast agent slowly fills and accumulates. Heterogeneous enhancement pattern may occur — thrombosed or phlebolith-filled areas do not enhance.
Report Sentence
On contrast-enhanced MRI, the lesion shows minimal enhancement in early phase and progressive enhancement in delayed phase, consistent with slow-flow characteristics of venous malformation.
On non-contrast CT, round, lamellar calcifications (phleboliths) may be detected within venous malformation. The CT appearance of phleboliths is characteristic: showing concentric ring-like calcification pattern. This finding is rarely seen in other soft tissue masses and strongly supports the diagnosis of venous malformation. CT also evaluates the extent of the lesion and its relationship to adjacent bony structures.
Report Sentence
On non-contrast CT, round calcifications with lamellar structure (phleboliths) are identified within the soft tissue lesion, supporting the diagnosis of venous malformation.
Criteria
Single, isolated lesion, no family history, somatic TIE2 mutation
Distinct Features
Most common type (95%+). Can occur in any anatomic region. Size varies from a few mm to cm. Treatment is sclerotherapy or surgery for symptomatic lesions.
Criteria
Multiple cutaneous and visceral (especially GI tract) venous malformations, autosomal dominant TIE2 germline mutation
Distinct Features
Rare but clinically significant. GI tract VMs may lead to chronic bleeding and iron deficiency anemia. Skin lesions appear as characteristic blue-black nodules.
Criteria
Similar to venous malformation but contains glomus cells in vessel wall, GLMN mutation, may be familial, firmer on palpation
Distinct Features
More cobalt blue than VM, firmer (due to glomus cells), less compressible. On US, more heterogeneous and fewer venous channel appearance compared to VM. Sclerotherapy response is lower than VM.
Distinguishing Feature
Infantile hemangioma is high-flow (intense arterial Doppler, low RI), solid and shows proliferation — VM is low-flow, compressible and fills with Valsalva. Hemangioma involutes, VM does not.
Distinguishing Feature
Lymphatic malformation has multiloculated cystic structure (anechoic cysts separated by thin septae), completely avascular on Doppler, no Valsalva filling. VM may have phleboliths and minimal venous flow.
Distinguishing Feature
Hematoma is associated with trauma history, shows time-dependent echogenicity change (acute hyperechoic→chronic anechoic), avascular on Doppler, not compressible and no Valsalva response.
Urgency
routineManagement
conservativeBiopsy
Not NeededFollow-up
12-monthVenous malformations are benign lesions but do not show spontaneous regression. Treatment indications: pain, functional limitation, cosmetic concern, recurrent thrombosis. First-line treatment is percutaneous sclerotherapy (ethanol, bleomycin, STS). Surgical resection is second choice as complete removal is difficult in extensive lesions. Compression stockings are helpful for symptom control. Sirolimus (mTOR inhibitor) may be effective in extensive or treatment-resistant VMs.
Venous malformations do not involute and have lifelong growth potential. Sclerotherapy (ethanol, STS, bleomycin) is the primary treatment. Surgical resection is performed in selected cases. Coagulopathy (localized intravascular coagulopathy — LIC) may develop; D-dimer and fibrinogen monitoring is recommended.